The Evolving Landscape of Polyp Management: Balancing Surveillance, Minimally Invasive Removal, and Risk Stratification
Once a polyp is detected, the management strategy is no longer a one-size-fits-all approach. The evolving landscape of polyp management emphasizes a nuanced balance between surveillance, minimally invasive removal techniques, and risk stratification, all tailored to the specific characteristics of the polyp and the individual patient.
The decision to remove a polyp or opt for surveillance depends largely on its size, morphology (shape and appearance), location, and the patient's risk factors for colorectal cancer. Small, benign-appearing polyps in low-risk individuals may be amenable to surveillance with repeat colonoscopies at longer intervals. However, larger polyps, those with features suggestive of advanced neoplasia (precancerous changes), or polyps in high-risk individuals (e.g., those with a family history of colorectal cancer or certain genetic syndromes) typically warrant removal.
Minimally invasive removal techniques have become the standard for most colorectal polyps. Polypectomy, the removal of polyps during colonoscopy, is typically performed using a snare that is passed through the colonoscope and used to encircle and excise the polyp. For larger or more complex polyps, advanced endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), may be necessary. EMR involves injecting fluid beneath the polyp to lift it away from the deeper layers of the colon wall before resection, while ESD allows for the en bloc (in one piece) removal of larger lesions, including early-stage cancers.
Risk stratification plays a crucial role in determining the intensity of surveillance after polyp removal. Factors such as the size, number, and histology (microscopic appearance) of the removed polyps, as well as the presence of high-risk features like villous architecture or high-grade dysplasia, influence the recommended follow-up colonoscopy intervals. Patients with low-risk polyps may be placed on a longer surveillance schedule, while those with high-risk lesions require more frequent follow-up to detect any recurrence or new polyp growth.
The concept of "leave-in-place" strategies for very small, low-risk polyps in certain patient populations is also being explored. Advanced imaging techniques, such as CLE with AI-assisted characterization, may allow endoscopists to confidently identify diminutive hyperplastic polyps that have virtually no risk of progressing to cancer, potentially avoiding unnecessary polypectomies and reducing healthcare costs.
Beyond the colon, the management of polyps in other organ systems also involves a balance of surveillance and removal based on the specific risks associated with those polyps. For example, small, asymptomatic gastric polyps may be monitored endoscopically, while larger or symptomatic gastric polyps often require removal due to the potential for malignant transformation.
The evolving landscape of polyp management is driven by advancements in endoscopic imaging, AI-assisted characterization, and a better understanding of the natural history and risk factors associated with different types of polyps. The goal is to provide personalized and risk-adapted management strategies that maximize cancer prevention while minimizing the burden of unnecessary interventions and surveillance.
Chinese
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)